var eventsData = [{"Ticker":"JCI","EffectiveDate":"2017-02-01","Type":"EarningsBeatRevenueMiss","Title":"Before market open, JCI reports 2017 Q1's earning $0.53 per share and revenue $7096MM. This beats analyst's estimated EPS $0.52, misses estimated revenue $7150MM.","DailyReturn":"-3.36%","FiveDayReturnAfter":"-6.45%","FiveDayReturnBefore":"0.06%"},{"Ticker":"JCI","EffectiveDate":"2016-12-12","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"-0.2%","FiveDayReturnAfter":"-3.27%","FiveDayReturnBefore":"-3.57%"},{"Ticker":"JCI","EffectiveDate":"2016-11-28","Type":"RatingNeutral","Title":"Citigroup initiates coverage on JCI to Buy. Target Price is $54.","DailyReturn":"-2%","FiveDayReturnAfter":"-1.24%","FiveDayReturnBefore":"2.53%"},{"Ticker":"JCI","EffectiveDate":"2016-11-08","Type":"EarningsRevenueBeat","Title":"Before market open, JCI reports 2016 Q4's earning $1.21 per share and revenue $10218MM. This beats analyst's estimated EPS $1.01, beats estimated revenue $9510MM.","DailyReturn":"5.7%","FiveDayReturnAfter":"5.84%","FiveDayReturnBefore":"3.05%"},{"Ticker":"JCI","EffectiveDate":"2016-11-01","Type":"RatingNeutral","Title":"Goldman Sachs maintains JCI to Buy.","DailyReturn":"2.33%","FiveDayReturnAfter":"3.05%","FiveDayReturnBefore":"-9.61%"},{"Ticker":"JCI","EffectiveDate":"2016-10-24","Type":"RatingNeutral","Title":"Goldman Sachs initiates coverage on JCI to Buy.","DailyReturn":"0.74%","FiveDayReturnAfter":"-0.68%","FiveDayReturnBefore":"0.4%"},{"Ticker":"JCI","EffectiveDate":"2016-10-18","Type":"RatingNeutral","Title":"Baird initiates coverage on JCI to Outperform.","DailyReturn":"0.52%","FiveDayReturnAfter":"1.47%","FiveDayReturnBefore":"-2.26%"},{"Ticker":"JCI","EffectiveDate":"2016-09-28","Type":"RatingNeutral","Title":"Cowen & Co. initiates coverage on JCI to Outperform.","DailyReturn":"2.73%","FiveDayReturnAfter":"1.08%","FiveDayReturnBefore":"2.33%"},{"Ticker":"JCI","EffectiveDate":"2016-09-21","Type":"RatingNeutral","Title":"UBS maintains JCI to Buy. Target Price is $53; previously $51.","DailyReturn":"1.38%","FiveDayReturnAfter":"2.33%","FiveDayReturnBefore":"-2.04%"},{"Ticker":"JCI","EffectiveDate":"2016-09-16","Type":"RatingNeutral","Title":"UBS maintains JCI to Buy. Target Price is $51; previously $52.","DailyReturn":"0.6%","FiveDayReturnAfter":"1.52%","FiveDayReturnBefore":"-7.77%"},{"Ticker":"JCI","EffectiveDate":"2016-09-16","Type":"RatingNeutral","Title":"Bernstein initiates coverage on JCI to Outperform.","DailyReturn":"0.6%","FiveDayReturnAfter":"1.52%","FiveDayReturnBefore":"-7.77%"},{"Ticker":"JCI","EffectiveDate":"2016-09-09","Type":"RatingNeutral","Title":"Atlantic Equities assumes JCI to Overweight.","DailyReturn":"-4.51%","FiveDayReturnAfter":"-7.77%","FiveDayReturnBefore":"9.13%"},{"Ticker":"JCI","EffectiveDate":"2016-09-08","Type":"RatingNeutral","Title":"Macquarie maintains JCI to Outperform. Target Price is $55; previously $43.","DailyReturn":"1.35%","FiveDayReturnAfter":"-5.86%","FiveDayReturnBefore":"7.06%"},{"Ticker":"JCI","EffectiveDate":"2016-09-06","Type":"RatingNeutral","Title":"RBC Capital assumes JCI to Sector Perform.","DailyReturn":"7.26%","FiveDayReturnAfter":"1.11%","FiveDayReturnBefore":"4.23%"},{"Ticker":"JCI","EffectiveDate":"2016-08-23","Type":"RatingNeutral","Title":"Credit Suisse maintains JCI to Outperform. Target Price is $52.","DailyReturn":"1.75%","FiveDayReturnAfter":"-0.13%","FiveDayReturnBefore":"0.42%"},{"Ticker":"JCI","EffectiveDate":"2016-08-22","Type":"RatingNeutral","Title":"Credit Suisse maintains JCI to Outperform. Target Price is $52.","DailyReturn":"-1.37%","FiveDayReturnAfter":"-2.84%","FiveDayReturnBefore":"2.59%"},{"Ticker":"JCI","EffectiveDate":"2016-08-03","Type":"Dividend","Title":"The Firm pays dividend $0.23","DailyReturn":"0.37%","FiveDayReturnAfter":"-0.11%","FiveDayReturnBefore":"-1.25%"},{"Ticker":"JCI","EffectiveDate":"2016-08-01","Type":"RatingNeutral","Title":"Morgan Stanley maintains JCI to Overweight. Target Price is $52; previously $50.","DailyReturn":"0.41%","FiveDayReturnAfter":"-0.03%","FiveDayReturnBefore":"-0.41%"},{"Ticker":"JCI","EffectiveDate":"2016-07-21","Type":"EarningsBeatRevenueMiss","Title":"Before market open, JCI reports 2016 Q3's earning $1.07 per share and revenue $9516MM. This beats analyst's estimated EPS $1.03, misses estimated revenue $9620MM.","DailyReturn":"3.16%","FiveDayReturnAfter":"5.64%","FiveDayReturnBefore":"0.29%"},{"Ticker":"JCI","EffectiveDate":"2016-07-20","Type":"Dividend","Title":"The Firm pays dividend $0.205","DailyReturn":"0.52%","FiveDayReturnAfter":"5.81%","FiveDayReturnBefore":"0.25%"},{"Ticker":"JCI","EffectiveDate":"2016-05-24","Type":"RatingUpgrade","Title":"Credit Suisse upgrades JCI to Outperform.","DailyReturn":"2.81%","FiveDayReturnAfter":"3.41%","FiveDayReturnBefore":"2.35%"},{"Ticker":"JCI","EffectiveDate":"2016-04-21","Type":"EarningsRevenueBeat","Title":"Before market open, JCI reports 2016 Q2's earning $0.86 per share and revenue $9031MM. This beats analyst's estimated EPS $0.82, beats estimated revenue $9020MM.","DailyReturn":"5.94%","FiveDayReturnAfter":"8.01%","FiveDayReturnBefore":"0.42%"},{"Ticker":"JCI","EffectiveDate":"2016-04-20","Type":"Dividend","Title":"The Firm pays dividend $0.205","DailyReturn":"0.36%","FiveDayReturnAfter":"7.67%","FiveDayReturnBefore":"2.09%"},{"Ticker":"JCI","EffectiveDate":"2016-04-13","Type":"RatingNeutral","Title":"Morgan Stanley assumes JCI to Overweight. Target Price is $47.","DailyReturn":"2.05%","FiveDayReturnAfter":"2.09%","FiveDayReturnBefore":"1.54%"},{"Ticker":"JCI","EffectiveDate":"2016-01-29","Type":"RatingNeutral","Title":"Credit Suisse maintains JCI to Neutral. Target Price is $44; previously $34.66.","DailyReturn":"2.71%","FiveDayReturnAfter":"3.57%","FiveDayReturnBefore":"11%"},{"Ticker":"JCI","EffectiveDate":"2016-01-25","Type":"RatingNeutral","Title":"Barclays maintains JCI to Overweight. Target Price is $47; previously $52.","DailyReturn":"11.63%","FiveDayReturnAfter":"11.7%","FiveDayReturnBefore":"1.89%"},{"Ticker":"JCI","EffectiveDate":"2016-01-20","Type":"Dividend","Title":"The Firm pays dividend $0.205","DailyReturn":"-1.63%","FiveDayReturnAfter":"11.41%","FiveDayReturnBefore":"0.78%"},{"Ticker":"JCI","EffectiveDate":"2016-01-07","Type":"RatingNeutral","Title":"Oppenheimer initiates coverage on JCI to Outperform. Target Price is $48.","DailyReturn":"-2.53%","FiveDayReturnAfter":"-4.26%","FiveDayReturnBefore":"-4.83%"},{"Ticker":"JCI","EffectiveDate":"2015-12-15","Type":"RatingNeutral","Title":"RBC Capital downgrades JCI to Sector Perform from Outperform.","DailyReturn":"0.22%","FiveDayReturnAfter":"-1.87%","FiveDayReturnBefore":"-6.28%"},{"Ticker":"JCI","EffectiveDate":"2015-12-11","Type":"RatingNeutral","Title":"Barclays maintains JCI to Overweight. Target Price is $52; previously $54.","DailyReturn":"-1.51%","FiveDayReturnAfter":"-5.23%","FiveDayReturnBefore":"-2.33%"},{"Ticker":"JCI","EffectiveDate":"2015-12-02","Type":"RatingNeutral","Title":"William Blair downgrades JCI to Market Perform from Outperform.","DailyReturn":"-2.57%","FiveDayReturnAfter":"-5.16%","FiveDayReturnBefore":"-0.91%"},{"Ticker":"JCI","EffectiveDate":"2015-10-21","Type":"Dividend","Title":"The Firm pays dividend $0.205","DailyReturn":"-1%","FiveDayReturnAfter":"-1.2%","FiveDayReturnBefore":"2.45%"},{"Ticker":"JCI","EffectiveDate":"2015-10-02","Type":"RatingUpgrade","Title":"Nomura upgrades JCI to Buy. Target Price is $50; previously $53.","DailyReturn":"1.53%","FiveDayReturnAfter":"6.73%","FiveDayReturnBefore":"-1.02%"},{"Ticker":"JCI","EffectiveDate":"2015-09-30","Type":"RatingUpgrade","Title":"William Blair upgrades JCI to Outperform from Market Perform. Target Price is $50; previously $53.","DailyReturn":"0.2%","FiveDayReturnAfter":"5.19%","FiveDayReturnBefore":"-4.45%"},{"Ticker":"JCI","EffectiveDate":"2015-09-15","Type":"RatingNeutral","Title":"Susquehanna maintains JCI to Neutral. Target Price is $45; previously $52.","DailyReturn":"1.6%","FiveDayReturnAfter":"-1.48%","FiveDayReturnBefore":"1.76%"},{"Ticker":"JCI","EffectiveDate":"2015-08-24","Type":"RatingNeutral","Title":"Credit Suisse initiates coverage on JCI to Neutral. Target Price is $49.","DailyReturn":"-3.67%","FiveDayReturnAfter":"1.24%","FiveDayReturnBefore":"-4.56%"},{"Ticker":"JCI","EffectiveDate":"2015-08-12","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades JCI to Buy from Neutral.","DailyReturn":"0.15%","FiveDayReturnAfter":"0.6%","FiveDayReturnBefore":"-1.13%"},{"Ticker":"JCI","EffectiveDate":"2015-07-27","Type":"RatingNeutral","Title":"Barclays maintains JCI to Overweight. Target Price is $54; previously $57.","DailyReturn":"-0.41%","FiveDayReturnAfter":"4.16%","FiveDayReturnBefore":"-4.69%"},{"Ticker":"JCI","EffectiveDate":"2015-07-22","Type":"Dividend","Title":"The Firm pays dividend $0.205","DailyReturn":"-1.8%","FiveDayReturnAfter":"-3.86%","FiveDayReturnBefore":"-0.07%"},{"Ticker":"JCI","EffectiveDate":"2015-06-11","Type":"RatingNeutral","Title":"Macquarie maintains JCI to Neutral. Target Price is $54; previously $48.","DailyReturn":"0.32%","FiveDayReturnAfter":"-0.49%","FiveDayReturnBefore":"-0.19%"},{"Ticker":"JCI","EffectiveDate":"2015-06-10","Type":"RatingNeutral","Title":"Buckingham Research assumes JCI to Buy. Target Price is $63.","DailyReturn":"0.59%","FiveDayReturnAfter":"-0.77%","FiveDayReturnBefore":"-0.32%"},{"Ticker":"JCI","EffectiveDate":"2015-05-28","Type":"RatingUpgrade","Title":"UBS upgrades JCI to Buy from Neutral. Target Price is $59; previously $51.","DailyReturn":"-0.04%","FiveDayReturnAfter":"-0.54%","FiveDayReturnBefore":"1.43%"},{"Ticker":"JCI","EffectiveDate":"2015-04-28","Type":"RatingNeutral","Title":"Citigroup maintains JCI to Neutral. Target Price is $54; previously $51.","DailyReturn":"-0.1%","FiveDayReturnAfter":"-0.35%","FiveDayReturnBefore":"-6.11%"},{"Ticker":"JCI","EffectiveDate":"2015-04-24","Type":"RatingNeutral","Title":"Nomura maintains JCI to Neutral. Target Price is $50; previously $46.","DailyReturn":"-5.98%","FiveDayReturnAfter":"-7.83%","FiveDayReturnBefore":"-1.19%"},{"Ticker":"JCI","EffectiveDate":"2015-04-22","Type":"Dividend","Title":"The Firm pays dividend $0.205","DailyReturn":"0.55%","FiveDayReturnAfter":"-5.81%","FiveDayReturnBefore":"-1.51%"},{"Ticker":"JCI","EffectiveDate":"2015-04-01","Type":"RatingNeutral","Title":"JP Morgan maintains JCI to Neutral. Target Price is $55; previously $52.","DailyReturn":"0.04%","FiveDayReturnAfter":"-0.11%","FiveDayReturnBefore":"-0.6%"},{"Ticker":"JCI","EffectiveDate":"2015-03-11","Type":"RatingNeutral","Title":"Deutsche Bank maintains JCI to Hold. Target Price is $55; previously $56.","DailyReturn":"-0.19%","FiveDayReturnAfter":"1.52%","FiveDayReturnBefore":"-3.49%"},{"Ticker":"JCI","EffectiveDate":"2015-03-03","Type":"RatingNeutral","Title":"Deutsche Bank maintains JCI to Hold. Target Price is $56; previously $54.","DailyReturn":"-0.32%","FiveDayReturnAfter":"-1.72%","FiveDayReturnBefore":"1.79%"},{"Ticker":"JCI","EffectiveDate":"2015-01-21","Type":"Dividend","Title":"The Firm pays dividend $0.18","DailyReturn":"0.42%","FiveDayReturnAfter":"-0.83%","FiveDayReturnBefore":"-2.66%"},{"Ticker":"JCI","EffectiveDate":"2015-01-12","Type":"RatingNeutral","Title":"Nomura initiates coverage on JCI to Neutral. Target Price is $46.","DailyReturn":"-1.02%","FiveDayReturnAfter":"-2.83%","FiveDayReturnBefore":"0.25%"},{"Ticker":"JCI","EffectiveDate":"2014-12-23","Type":"RatingNeutral","Title":"Ascendiant Capital initiates coverage on JCI to Buy. Target Price is $68.","DailyReturn":"1.51%","FiveDayReturnAfter":"1.16%","FiveDayReturnBefore":"4.94%"},{"Ticker":"JCI","EffectiveDate":"2014-12-03","Type":"RatingNeutral","Title":"UBS maintains JCI to Neutral. Target Price is $51; previously $50.","DailyReturn":"0.67%","FiveDayReturnAfter":"0.46%","FiveDayReturnBefore":"1.49%"},{"Ticker":"JCI","EffectiveDate":"2014-10-22","Type":"Dividend","Title":"The Firm pays dividend $0.18","DailyReturn":"-1.57%","FiveDayReturnAfter":"3.28%","FiveDayReturnBefore":"3%"},{"Ticker":"JCI","EffectiveDate":"2014-10-14","Type":"RatingNeutral","Title":"Wells Fargo downgrades JCI to Market Perform from Outperform.","DailyReturn":"-4.45%","FiveDayReturnAfter":"-3.37%","FiveDayReturnBefore":"-3.33%"},{"Ticker":"JCI","EffectiveDate":"2014-10-13","Type":"RatingNeutral","Title":"RBC Capital downgrades JCI to Outperform from Top Pick. Target Price is $49; previously $61.","DailyReturn":"-1.16%","FiveDayReturnAfter":"-4.47%","FiveDayReturnBefore":"-3.43%"},{"Ticker":"JCI","EffectiveDate":"2014-09-22","Type":"RatingNeutral","Title":"JP Morgan maintains JCI to Neutral. Target Price is $57; previously $51.","DailyReturn":"-0.57%","FiveDayReturnAfter":"-1.52%","FiveDayReturnBefore":"1.3%"},{"Ticker":"JCI","EffectiveDate":"2014-07-23","Type":"Dividend","Title":"The Firm pays dividend $0.18","DailyReturn":"-0.46%","FiveDayReturnAfter":"-1.11%","FiveDayReturnBefore":"-0.19%"},{"Ticker":"JCI","EffectiveDate":"2014-07-21","Type":"RatingNeutral","Title":"Citigroup maintains JCI to Neutral. Target Price is $51; previously $50.","DailyReturn":"0.26%","FiveDayReturnAfter":"0.33%","FiveDayReturnBefore":"-0.13%"},{"Ticker":"JCI","EffectiveDate":"2014-07-18","Type":"EarningsBeatRevenueMiss","Title":"Before market open, JCI reports 2014 Q3's earning $0.84 per share and revenue $10810MM. This beats analyst's estimated EPS $0.83, misses estimated revenue $10820MM.","DailyReturn":"1.29%","FiveDayReturnAfter":"0.73%","FiveDayReturnBefore":"-0.35%"},{"Ticker":"JCI","EffectiveDate":"2014-07-14","Type":"RatingNeutral","Title":"Barclays maintains JCI to Overweight. Target Price is $59; previously $60.","DailyReturn":"-0.06%","FiveDayReturnAfter":"-0.13%","FiveDayReturnBefore":"-1.42%"},{"Ticker":"JCI","EffectiveDate":"2014-06-24","Type":"RatingNeutral","Title":"Susquehanna initiates coverage on JCI to Neutral. Target Price is $57.","DailyReturn":"-0.82%","FiveDayReturnAfter":"-0.8%","FiveDayReturnBefore":"1.31%"},{"Ticker":"JCI","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"Deutsche Bank maintains JCI to Hold. Target Price is $52; previously $54.","DailyReturn":"-0.44%","FiveDayReturnAfter":"-3.6%","FiveDayReturnBefore":"3.97%"},{"Ticker":"JCI","EffectiveDate":"2014-04-23","Type":"Dividend","Title":"The Firm pays dividend $0.18","DailyReturn":"-0.07%","FiveDayReturnAfter":"-3.45%","FiveDayReturnBefore":"4.51%"},{"Ticker":"JCI","EffectiveDate":"2014-04-22","Type":"RatingNeutral","Title":"JP Morgan maintains JCI to Neutral. Target Price is $52; previously $54.","DailyReturn":"0.25%","FiveDayReturnAfter":"-3.56%","FiveDayReturnBefore":"4.52%"},{"Ticker":"JCI","EffectiveDate":"2014-02-19","Type":"RatingNeutral","Title":"FBR Capital initiates coverage on JCI to Outperform. Target Price is $65.","DailyReturn":"-0.99%","FiveDayReturnAfter":"0.63%","FiveDayReturnBefore":"1.86%"},{"Ticker":"JCI","EffectiveDate":"2014-01-27","Type":"RatingNeutral","Title":"Barclays maintains JCI to Overweight from Overweight. Target Price is $60; previously $62.","DailyReturn":"0.07%","FiveDayReturnAfter":"2.72%","FiveDayReturnBefore":"-4.07%"},{"Ticker":"JCI","EffectiveDate":"2014-01-24","Type":"RatingNeutral","Title":"Deutsche Bank maintains JCI to Hold. Target Price is $54.","DailyReturn":"-2.78%","FiveDayReturnAfter":"-2.14%","FiveDayReturnBefore":"-1.42%"},{"Ticker":"JCI","EffectiveDate":"2014-01-24","Type":"RatingNeutral","Title":"Citigroup maintains JCI to Neutral. Target Price is $50.","DailyReturn":"-2.78%","FiveDayReturnAfter":"-2.14%","FiveDayReturnBefore":"-1.42%"},{"Ticker":"JCI","EffectiveDate":"2014-01-22","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":"0.29%","FiveDayReturnAfter":"-3.1%","FiveDayReturnBefore":"2.52%"},{"Ticker":"JCI","EffectiveDate":"2013-12-19","Type":"RatingNeutral","Title":"Deutsche Bank maintains JCI to Hold. Target Price is $54; previously $55.","DailyReturn":"-0.4%","FiveDayReturnAfter":"3.89%","FiveDayReturnBefore":"4.95%"},{"Ticker":"JCI","EffectiveDate":"2013-12-12","Type":"RatingUpgrade","Title":"Barclays upgrades JCI to Overweight from Equal-weight. Target Price is $64; previously $52.","DailyReturn":"1.64%","FiveDayReturnAfter":"4.95%","FiveDayReturnBefore":"-0.88%"},{"Ticker":"JCI","EffectiveDate":"2013-12-10","Type":"RatingUpgrade","Title":"RBC Capital upgrades JCI to Top Pick from Outperform. Target Price is $61.","DailyReturn":"-0.55%","FiveDayReturnAfter":"0.5%","FiveDayReturnBefore":"0.1%"},{"Ticker":"JCI","EffectiveDate":"2013-12-04","Type":"RatingUpgrade","Title":"RBC Capital upgrades JCI to Outperform from Sector Perform. Target Price is $61; previously $45.","DailyReturn":"-0.92%","FiveDayReturnAfter":"-0.87%","FiveDayReturnBefore":"-1.49%"},{"Ticker":"JCI","EffectiveDate":"2013-11-25","Type":"RatingNeutral","Title":"Citigroup maintains JCI to Neutral. Target Price is $50; previously $47.","DailyReturn":"0%","FiveDayReturnAfter":"-1.91%","FiveDayReturnBefore":"3.46%"},{"Ticker":"JCI","EffectiveDate":"2013-11-21","Type":"RatingNeutral","Title":"Deutsche Bank maintains JCI to Hold. Target Price is $50; previously $48.","DailyReturn":"1.42%","FiveDayReturnAfter":"2.26%","FiveDayReturnBefore":"1.13%"},{"Ticker":"JCI","EffectiveDate":"2013-10-30","Type":"RatingNeutral","Title":"Deutsche Bank maintains JCI to Hold. Target Price is $48; previously $46.","DailyReturn":"0%","FiveDayReturnAfter":"0.9%","FiveDayReturnBefore":"1.04%"},{"Ticker":"JCI","EffectiveDate":"2013-10-29","Type":"EarningsRelease","Title":"After market close, JCI reports 2013 Q4's earning $0.95 per share and revenue $11050MM. This meets analyst's estimated EPS $0.95, beats estimated revenue $10960MM.","DailyReturn":"0.85%","FiveDayReturnAfter":"1.34%","FiveDayReturnBefore":"1.24%"},{"Ticker":"JCI","EffectiveDate":"2013-10-28","Type":"RatingNeutral","Title":"Deutsche Bank maintains JCI to Hold. Target Price is $55; previously $56.","DailyReturn":"-0.95%","FiveDayReturnAfter":"0.16%","FiveDayReturnBefore":"1.9%"},{"Ticker":"JCI","EffectiveDate":"2013-10-23","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":"0.41%","FiveDayReturnAfter":"1.04%","FiveDayReturnBefore":"3.19%"},{"Ticker":"JCI","EffectiveDate":"2013-09-30","Type":"RatingNeutral","Title":"Morgan Stanley downgrades JCI to Underweight from Overweight. Target Price is $40; previously $45.","DailyReturn":"0.08%","FiveDayReturnAfter":"-0.25%","FiveDayReturnBefore":"0.17%"},{"Ticker":"JCI","EffectiveDate":"2013-07-24","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":"0.22%","FiveDayReturnAfter":"-0.48%","FiveDayReturnBefore":"-0.25%"},{"Ticker":"JCI","EffectiveDate":"2013-07-18","Type":"EarningsBeatRevenueMiss","Title":"Before market open, JCI reports 2013 Q3's earning $0.83 per share and revenue $10800MM. This beats analyst's estimated EPS $0.75, misses estimated revenue $10990MM.","DailyReturn":"0%","FiveDayReturnAfter":"-0.16%","FiveDayReturnBefore":"0.08%"},{"Ticker":"JCI","EffectiveDate":"2013-05-28","Type":"RatingUpgrade","Title":"Wells Fargo upgrades JCI to Outperform from Neutral.","DailyReturn":"0.67%","FiveDayReturnAfter":"-1.29%","FiveDayReturnBefore":"0.02%"},{"Ticker":"JCI","EffectiveDate":"2013-05-13","Type":"RatingUpgrade","Title":"Lazard upgrades JCI to Buy from Neutral.","DailyReturn":"-0.02%","FiveDayReturnAfter":"1.14%","FiveDayReturnBefore":"5.58%"},{"Ticker":"JCI","EffectiveDate":"2013-04-24","Type":"RatingNeutral","Title":"Jefferies maintains JCI to Hold. Target Price is $35; previously $34.","DailyReturn":"-0.61%","FiveDayReturnAfter":"3.9%","FiveDayReturnBefore":"-1.69%"},{"Ticker":"JCI","EffectiveDate":"2013-04-24","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":"-0.61%","FiveDayReturnAfter":"3.9%","FiveDayReturnBefore":"-1.69%"},{"Ticker":"JCI","EffectiveDate":"2013-04-23","Type":"RevenueBeat","Title":"Before market open, JCI reports 2013 Q2's earning $0.42 per share and revenue $10400MM. This meets analyst's estimated EPS $0.42, misses estimated revenue $10460MM.","DailyReturn":"0.84%","FiveDayReturnAfter":"4.87%","FiveDayReturnBefore":"-1.83%"},{"Ticker":"JCI","EffectiveDate":"2013-04-23","Type":"RatingUpgrade","Title":"Baird upgrades JCI to Outperform from Neutral. Target Price is $44; previously $36.","DailyReturn":"0.84%","FiveDayReturnAfter":"4.87%","FiveDayReturnBefore":"-1.83%"},{"Ticker":"JCI","EffectiveDate":"2013-04-23","Type":"RatingNeutral","Title":"Jefferies maintains JCI to Hold. Target Price is $34; previously $31.","DailyReturn":"0.84%","FiveDayReturnAfter":"4.87%","FiveDayReturnBefore":"-1.83%"},{"Ticker":"JCI","EffectiveDate":"2013-04-22","Type":"RatingUpgrade","Title":"Baird upgrades JCI to Outperform from Neutral.","DailyReturn":"-1.69%","FiveDayReturnAfter":"0.83%","FiveDayReturnBefore":"-2.92%"},{"Ticker":"JCI","EffectiveDate":"2013-03-14","Type":"RatingUpgrade","Title":"Credit Agricole upgrades JCI to Buy from Outperform. Target Price is $50; previously $36.","DailyReturn":"0.47%","FiveDayReturnAfter":"-0.85%","FiveDayReturnBefore":"-1.56%"},{"Ticker":"JCI","EffectiveDate":"2013-01-23","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"0%","FiveDayReturnAfter":"-1.91%","FiveDayReturnBefore":"3.08%"},{"Ticker":"JCI","EffectiveDate":"2013-01-23","Type":"RatingNeutral","Title":"Deutsche Bank maintains JCI to Hold. Target Price is $33.5; previously $29.","DailyReturn":"0%","FiveDayReturnAfter":"-1.91%","FiveDayReturnBefore":"3.08%"},{"Ticker":"JCI","EffectiveDate":"2013-01-22","Type":"RatingNeutral","Title":"Lazard downgrades JCI to Neutral from Buy.","DailyReturn":"-0.38%","FiveDayReturnAfter":"-1.67%","FiveDayReturnBefore":"3.63%"},{"Ticker":"JCI","EffectiveDate":"2013-01-18","Type":"EarningsRevenueBeat","Title":"Before market open, JCI reports 2013 Q1's earning $0.52 per share and revenue $10420MM. This beats analyst's estimated EPS $0.51, beats estimated revenue $10240MM.","DailyReturn":"0.09%","FiveDayReturnAfter":"0.12%","FiveDayReturnBefore":"3.07%"},{"Ticker":"JCI","EffectiveDate":"2012-12-20","Type":"RatingNeutral","Title":"JP Morgan maintains JCI to Neutral. Target Price is $31; previously $29.","DailyReturn":"0.82%","FiveDayReturnAfter":"-1.13%","FiveDayReturnBefore":"1.72%"},{"Ticker":"JCI","EffectiveDate":"2012-12-20","Type":"RatingNeutral","Title":"Deutsche Bank maintains JCI to Hold. Target Price is $29; previously $28.","DailyReturn":"0.82%","FiveDayReturnAfter":"-1.13%","FiveDayReturnBefore":"1.72%"},{"Ticker":"JCI","EffectiveDate":"2012-12-20","Type":"RatingNeutral","Title":"Jefferies maintains JCI to Hold. Target Price is $30; previously $27.","DailyReturn":"0.82%","FiveDayReturnAfter":"-1.13%","FiveDayReturnBefore":"1.72%"},{"Ticker":"JCI","EffectiveDate":"2012-11-01","Type":"RatingNeutral","Title":"Needham downgrades JCI to Hold from Buy.","DailyReturn":"2.9%","FiveDayReturnAfter":"3.29%","FiveDayReturnBefore":"-1.95%"},{"Ticker":"JCI","EffectiveDate":"2012-11-01","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains JCI to Buy. Target Price is $33; previously $35.","DailyReturn":"2.9%","FiveDayReturnAfter":"3.29%","FiveDayReturnBefore":"-1.95%"},{"Ticker":"JCI","EffectiveDate":"2012-10-31","Type":"RatingNeutral","Title":"Deutsche Bank maintains JCI to Hold. Target Price is $28.5; previously $32.","DailyReturn":"0%","FiveDayReturnAfter":"6.06%","FiveDayReturnBefore":"-2.6%"},{"Ticker":"JCI","EffectiveDate":"2012-10-31","Type":"RatingNeutral","Title":"Macquarie downgrades JCI to Neutral from Outperform.","DailyReturn":"0%","FiveDayReturnAfter":"6.06%","FiveDayReturnBefore":"-2.6%"},{"Ticker":"JCI","EffectiveDate":"2012-10-31","Type":"RatingNeutral","Title":"Jefferies maintains JCI to Hold. Target Price is $27; previously $26.","DailyReturn":"0%","FiveDayReturnAfter":"6.06%","FiveDayReturnBefore":"-2.6%"},{"Ticker":"JCI","EffectiveDate":"2012-10-31","Type":"RatingNeutral","Title":"UBS maintains JCI to Neutral. Target Price is $26; previously $27.","DailyReturn":"0%","FiveDayReturnAfter":"6.06%","FiveDayReturnBefore":"-2.6%"},{"Ticker":"JCI","EffectiveDate":"2012-10-12","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"-0.84%","FiveDayReturnAfter":"1.92%","FiveDayReturnBefore":"-4.41%"},{"Ticker":"JCI","EffectiveDate":"2012-10-01","Type":"Dividend","Title":"The Firm pays dividend $0","DailyReturn":"1.9%","FiveDayReturnAfter":"0.86%","FiveDayReturnBefore":"0.4%"},{"Ticker":"JCI","EffectiveDate":"2012-07-25","Type":"Dividend","Title":"The Firm pays dividend $0.12428","DailyReturn":"1.45%","FiveDayReturnAfter":"7.57%","FiveDayReturnBefore":"-2.26%"},{"Ticker":"JCI","EffectiveDate":"2012-07-24","Type":"RatingNeutral","Title":"Sterne Agee maintains JCI to Neutral. Target Price is $28; previously $35.","DailyReturn":"-0.87%","FiveDayReturnAfter":"4.56%","FiveDayReturnBefore":"-0.96%"},{"Ticker":"JCI","EffectiveDate":"2012-07-23","Type":"RatingNeutral","Title":"Morgan Stanley maintains JCI to Overweight. Target Price is $38; previously $42.","DailyReturn":"-1.69%","FiveDayReturnAfter":"3.19%","FiveDayReturnBefore":"1.32%"},{"Ticker":"JCI","EffectiveDate":"2012-07-20","Type":"RatingNeutral","Title":"UBS maintains JCI to Neutral. Target Price is $27; previously $28.","DailyReturn":"-0.9%","FiveDayReturnAfter":"-0.57%","FiveDayReturnBefore":"3.88%"},{"Ticker":"JCI","EffectiveDate":"2012-07-20","Type":"RatingNeutral","Title":"Jefferies maintains JCI to Hold. Target Price is $26; previously $28.","DailyReturn":"-0.9%","FiveDayReturnAfter":"-0.57%","FiveDayReturnBefore":"3.88%"},{"Ticker":"JCI","EffectiveDate":"2012-07-20","Type":"RatingNeutral","Title":"Deutsche Bank downgrades JCI to Hold from Buy. Target Price is $32; previously $35.","DailyReturn":"-0.9%","FiveDayReturnAfter":"-0.57%","FiveDayReturnBefore":"3.88%"},{"Ticker":"JCI","EffectiveDate":"2012-07-20","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains JCI to Buy. Target Price is $35; previously $38.","DailyReturn":"-0.9%","FiveDayReturnAfter":"-0.57%","FiveDayReturnBefore":"3.88%"},{"Ticker":"JCI","EffectiveDate":"2012-07-20","Type":"RatingNeutral","Title":"JP Morgan maintains JCI to Neutral. Target Price is $33; previously $36.","DailyReturn":"-0.9%","FiveDayReturnAfter":"-0.57%","FiveDayReturnBefore":"3.88%"},{"Ticker":"JCI","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"Bank of America maintains JCI to Buy. Target Price is $40; previously $44.","DailyReturn":"-0.03%","FiveDayReturnAfter":"-2.08%","FiveDayReturnBefore":"2.44%"},{"Ticker":"JCI","EffectiveDate":"2012-07-19","Type":"EarningsRevenueMiss","Title":"Before market open, JCI reports 2012 Q3's earning $0.64 per share and revenue $10580MM. This misses analyst's estimated EPS $0.66, misses estimated revenue $10810MM.","DailyReturn":"-0.03%","FiveDayReturnAfter":"-2.08%","FiveDayReturnBefore":"2.44%"},{"Ticker":"JCI","EffectiveDate":"2012-07-18","Type":"RatingNeutral","Title":"JP Morgan initiates coverage on JCI to Neutral. Target Price is $36.","DailyReturn":"1.27%","FiveDayReturnAfter":"-2.26%","FiveDayReturnBefore":"0.44%"},{"Ticker":"JCI","EffectiveDate":"2012-07-16","Type":"RatingNeutral","Title":"UBS maintains JCI to Neutral. Target Price is $28; previously $30.","DailyReturn":"0.57%","FiveDayReturnAfter":"1.32%","FiveDayReturnBefore":"-1.6%"},{"Ticker":"JCI","EffectiveDate":"2012-07-09","Type":"RatingNeutral","Title":"Jefferies maintains JCI to Hold. Target Price is $28; previously $36.","DailyReturn":"1.25%","FiveDayReturnAfter":"-1.6%","FiveDayReturnBefore":"2.42%"},{"Ticker":"JCI","EffectiveDate":"2012-07-09","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains JCI to Buy. Target Price is $38; previously $40.","DailyReturn":"1.25%","FiveDayReturnAfter":"-1.6%","FiveDayReturnBefore":"2.42%"},{"Ticker":"JCI","EffectiveDate":"2012-07-06","Type":"RatingNeutral","Title":"Wunderlich maintains JCI to Buy. Target Price is $45.","DailyReturn":"-2.42%","FiveDayReturnAfter":"-5.71%","FiveDayReturnBefore":"4.14%"},{"Ticker":"JCI","EffectiveDate":"2012-06-25","Type":"RatingNeutral","Title":"Barclays maintains JCI to Equal-Weight. Target Price is $37; previously $35.","DailyReturn":"-2.81%","FiveDayReturnAfter":"1.08%","FiveDayReturnBefore":"-2.99%"},{"Ticker":"JCI","EffectiveDate":"2012-06-07","Type":"RatingNeutral","Title":"Deutsche Bank maintains JCI to Buy. Target Price is $38.5; previously $39.","DailyReturn":"0.37%","FiveDayReturnAfter":"-2.24%","FiveDayReturnBefore":"-0.48%"},{"Ticker":"JCI","EffectiveDate":"2012-04-25","Type":"Dividend","Title":"The Firm pays dividend $0.12428","DailyReturn":"0.53%","FiveDayReturnAfter":"3.09%","FiveDayReturnBefore":"-0.51%"},{"Ticker":"JCI","EffectiveDate":"2012-04-23","Type":"RatingNeutral","Title":"Jefferies maintains JCI to Hold. Target Price is $36; previously $35.","DailyReturn":"-1.17%","FiveDayReturnAfter":"4.49%","FiveDayReturnBefore":"1.58%"},{"Ticker":"JCI","EffectiveDate":"2012-04-20","Type":"EarningsRelease","Title":"Before market open, JCI reports 2012 Q2's earning $0.55 per share and revenue $10565MM..","DailyReturn":"0.54%","FiveDayReturnAfter":"3.41%","FiveDayReturnBefore":"0.41%"},{"Ticker":"JCI","EffectiveDate":"2012-04-13","Type":"RatingUpgrade","Title":"Deutsche Bank upgrades JCI to Buy from Hold. Target Price is $39; previously $40.","DailyReturn":"-0.62%","FiveDayReturnAfter":"0.41%","FiveDayReturnBefore":"-0.87%"},{"Ticker":"JCI","EffectiveDate":"2012-03-07","Type":"RatingNeutral","Title":"Guggenheim maintains JCI to Buy. Target Price is $41; previously $41.95.","DailyReturn":"1.59%","FiveDayReturnAfter":"2.89%","FiveDayReturnBefore":"-1.06%"}];